glp-1 news 2025 october 9 Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford glp-1 news october 9 2025
Description
Lilly announced the topline results from its phase 3b "TOGETHER PsA" trial, showing that the combination use of ixekizumab (Taltz) and tirzepatide (Zepbound) was superior to IXE alone, yielding both significant weight loss and ACR50 disease control in adults with active psoriatic arthritis (PsA).
Month Maintenance (2.2mg): Ongoing maintenance $1,297
GLP-1 has transformed the approach to weight loss, and some people using it notice an increase in hair loss, which can be concerning.
Satisfy your cravings with delicious GLP-1 dessert recipes that support weight loss
Lakeland, FL
Disclaimer: This product is not intended to diagnose, treat, cure, or prevent any disease
